
|Videos|October 7, 2021
Study assesses the efficacy of Rezum water vapor therapy in treating BPH
Author(s)Urology Times staff
Advertisement
In this video, Dean Elterman, MD, MSc, FRCSC, discusses the background, findings, and takeaways of the study, “Rezūm water vapor therapy for large volume (≥80 mL) benign prostatic enlargement: large, multi-center cohort,” presented at the 2021 American Urological Association annual meeting. Elterman is an associate professor of urology at the University of Toronto and an attending urologist at the University Health Network, Toronto, Canada.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
CMS' 2027 PFS proposed rule: Modifier -25 cuts, G2211 overhaul loom
2
The UroOnc Minute: Cribriform Histology in Prostate Cancer, With Tyler Seibert, MD, PhD
3
Rezūm shows greater 1-year BPH symptom relief vs pharmacotherapy
4
FDA grants breakthrough therapy, fast track designations to kidney cancer imaging agent
5










